P064. TOP1210 narrow spectrum kinase inhibitor demonstrates superior activity and improved safety profile potential compared with corticosteroid and immunomodulators in preclinical models of colitis
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.